Cullen Capital Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cullen Capital Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$637,989
-32.9%
7,122
-36.2%
0.01%
-12.5%
Q2 2023$950,162
-0.5%
11,160
-3.3%
0.01%
-11.1%
Q1 2023$955,018
+29.0%
11,541
+22.6%
0.01%0.0%
Q4 2022$740,175
-36.2%
9,411
-39.9%
0.01%
-25.0%
Q3 2022$1,160,000
+11.3%
15,667
-2.0%
0.01%
+20.0%
Q2 2022$1,042,000
+3.1%
15,9840.0%0.01%
+11.1%
Q1 2022$1,011,000
+19.2%
15,9840.0%0.01%
+12.5%
Q4 2021$848,000
-8.8%
15,984
+21.3%
0.01%
-11.1%
Q3 2021$930,000
+4.8%
13,179
-1.0%
0.01%0.0%
Q2 2021$887,00013,3150.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders